Cite
MLA Citation
Suzette Delaloge et al.. “Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer.” European journal of cancer, vol. 166, 2022, pp. 300–308. http://access.bl.uk/ark:/81055/vdc_100153446316.0x00002b